Extended prophylaxis vs placebo: Major bleedinge
Extended prophylaxis showed no clear difference in major bleedinge compared with placebo (low certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Extended prophylaxis vs placebo Major bleedinge · patients with unprovoked venous thromboembolism Extended prophylaxis showed no clear difference in major bleedinge compared with placebo (low certainty). Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in… (2017) · Cochrane Headline outcomes only | OR 1.84 [0.87, 3.85] | 5 studies · 2043 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous… 2017 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.